Item 9 Labs (INLB) Cost of Revenue (2016 - 2023)
Item 9 Labs' Cost of Revenue history spans 12 years, with the latest figure at $1.9 million for Q2 2023.
- For Q2 2023, Cost of Revenue rose 809.18% year-over-year to $1.9 million; the TTM value through Jun 2023 reached -$5.0 million, down 136.47%, while the annual FY2022 figure was $1.8 million, 0.93% down from the prior year.
- Cost of Revenue reached $1.9 million in Q2 2023 per INLB's latest filing, down from $1.9 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $4.0 million in Q3 2020 to a low of -$9.3 million in Q3 2022.
- Average Cost of Revenue over 5 years is $90427.4, with a median of $385319.0 recorded in 2019.
- Peak YoY movement for Cost of Revenue: crashed 1606.07% in 2019, then skyrocketed 809.18% in 2023.
- A 5-year view of Cost of Revenue shows it stood at $176637.0 in 2019, then increased by 21.46% to $214537.0 in 2020, then surged by 104.83% to $439436.0 in 2021, then rose by 12.54% to $494549.0 in 2022, then surged by 280.94% to $1.9 million in 2023.
- Per Business Quant, the three most recent readings for INLB's Cost of Revenue are $1.9 million (Q2 2023), $1.9 million (Q1 2023), and $494549.0 (Q4 2022).